{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-22-000076","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2022-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.360794+00:00","generated_at":"2026-06-24T03:13:56.771077+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Penumbra Q2 revenue $208.3M (+13.1% YoY); GAAP operating loss vs prior-year income","bullets":["Revenue $208.3M, up 13.1% (15.3% constant currency); vascular $123.5M (+22.7%), neuro $84.8M (+1.5%).","GAAP operating loss of $0.1M vs income $10.3M in Q2 2021; non-GAAP operating income $1.6M (excl. Sixense amort.).","Gross margin 64.3% vs 64.4% prior; SG&A expenses rose to $114.6M from $90.6M.","FY2022 revenue guidance maintained at $860M-$875M; expects lower end due to FX; constant currency growth 15-17%."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-22-000076","json":"https://secwatch.observer/filing/0001321732-22-000076.json","markdown":"https://secwatch.observer/filing/0001321732-22-000076.md","text":"https://secwatch.observer/filing/0001321732-22-000076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173222000076/0001321732-22-000076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173222000076/pen-20220804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:13:56.771077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}